Lea Trela-Larsen
Lea Trela-Larsen
National Centre for Pharmacoeconomics Ireland
Verified email at tcd.ie
Title
Cited by
Cited by
Year
Preoperative psychosocial risk factors for poor outcomes at 1 and 5 years after total knee replacement: A cohort study of 266 patients
V Wylde, L Trela-Larsen, MR Whitehouse, AW Blom
Acta orthopaedica 88 (5), 530-536, 2017
402017
Body mass index, body dissatisfaction and adolescent smoking initiation
LJ Howe, L Trela-Larsen, M Taylor, J Heron, MR Munaf˛, AE Taylor
Drug and alcohol dependence 178, 143-149, 2017
202017
Chlamydia screening, retesting and repeat diagnoses in Cornwall, UK 2003–2009
KME Turner, PJ Horner, L Trela-Larsen, M Sharp, M May
Sexually transmitted infections 89 (1), 70-75, 2013
162013
The association between cement type and the subsequent risk of revision surgery in primary total hip replacement: 199, 205 hips from the National Joint Registry for Englandá…
L Trela-Larsen, A Sayers, AW Blom, JCJ Webb, MR Whitehouse
Acta orthopaedica 89 (1), 40-46, 2018
82018
Estimating an individual’s probability of revision surgery after knee replacement: a comparison of modeling approaches using a national data set
P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ...
American journal of epidemiology 187 (10), 2252-2262, 2018
62018
HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics
J Zheng, S Rodriguez, C Laurin, D Baird, L Trela-Larsen, ...
Bioinformatics 33 (1), 79-86, 2017
62017
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
J Leahy, C Hickey, D McConnell, O Cassidy, L Trela-Larsen, M Barry, ...
Value in Health, 2020
22020
Estimating patient-specific mortality after joint replacement: algorithm development and validation using national audit datasets
JM Wilkinson, L Trela-Larsen, C Bartz-Johannessen, A Sayers, P Aram, ...
Osteoarthritis and Cartilage 27, S229, 2019
12019
An evaluation of survival modelling approaches for personalised risk prediction after hip replacement for osteoarthritis
P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ...
Osteoarthritis and Cartilage 26, S281, 2018
12018
P5-S7. 07 Chlamydia screening in Cornwall: How often do young people get retested?
K Turner, L Trela-Larsen, P Gates, M May, P Horner
Sexually Transmitted Infections 87 (Suppl 1), A344-A345, 2011
12011
Understanding the challenges and uncertainties of seroprevalence studies for SARS-CoV-2
D McConnell, C Hickey, N Bargary, L Trela-Larsen, C Walsh, M Barry, ...
Preprints, 2020
2020
PMU52 The Reliability of Budget IMPACT Predictions for Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold
C Kennedy, L McCullagh, R Adams, L Trela-Larsen, L Tilson, M Barry
Value in Health 23, S612, 2020
2020
PMU65 Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold and Subsequent Price Negotiations
C Kennedy, L McCullagh, R Adams, L Trela-Larsen, L Tilson, M Barry
Value in Health 23, S613, 2020
2020
THEMED SECTION: COVID-19
CD Mullins, MF Drummond, S Ma, DD Kim, JT Cohen, PJ Neumann, ...
2020
Personalized estimation of one-year mortality risk after elective hip or knee arthroplasty for osteoarthritis: JointCalc model development and validation using the Nationalá…
L Trela-Larsen, G Kroken, C Bartz-Johannessen, A Sayers, P Aram, ...
Bone & Joint Research 9 (11), 808-820, 2020
2020
PCN284 PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN NON-SMALL CELL LUNG CANCER IN IRELAND
C Gorry, E Connolly, L Trela-Larsen, M Barry
Value in Health 22, S491, 2019
2019
PCN498 REAL-WORLD EVIDENCE ON THE UTILISATION OF ABIRATERONE AND ENZALUTAMIDE IN IRELAND
L Trela-Larsen, C Usher, L McCullagh, M Barry, C Walsh
Value in Health 22, S534, 2019
2019
AN EVALUATION OF SURVIVAL MODELLING APPROACHES FOR PERSONALIZED RISK PREDICTION AFTER HIP ARTHROPLASTY FOR OSTEOARTHRITIS
P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ...
Orthopaedic Proceedings 101 (SUPP_2), 27-27, 2019
2019
PCN244-REAL-WORLD EVIDENCE ON THE UTILISATION OF REGORAFENIB IN IRELAND
L Trela-Larsen, C Usher, L McCullagh, C Walsh
Value in Health 21, S55, 2018
2018
AN EVALUATION OF SURVIVAL MODELLING APPROACHES FOR PERSONALIZED RISK PREDICTION AFTER HIP ARTHROPLASTY FOR OSTEOARTHRITIS
P Aram, L Trela-Larsen, A Sayers, AF Hills, AW Blom, EV McCloskey, ...
Orthopaedic Proceedings 100 (SUPP_9), 31-31, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20